Analysis of Antihypertensive Drug Prescribing Based on the National Formulary and Hospital Formulary at the Inpatient Pharmacy Unit of Hospital X
DOI:
https://doi.org/10.35451/jfm.v9i1.3877Keywords:
Hypertension, National Formulary, Hospital Formulary, Antihypertensives, Prescription Appropriateness, Hospital XAbstract
Background: Around 1.28 billion adults worldwide suffer from hypertension, which is an increasingly serious health problem. According to the 2023 Indonesian Health Survey (SKI), the prevalence of hypertension in Indonesia is 34.7% in women and 26.9% in men. To ensure quality services and cost efficiency, all drug prescriptions in healthcare facilities must align with the National Formulary (FORNAS) and the Hospital Formulary under the National Health Insurance (JKN) system. Objective: to evaluate the level of compliance of antihypertensive drug prescriptions with FORNAS (Minister of Health Decree No. HK.01.07/MENKES/1199/2025) and the Hospital Formulary in 2025, and to identify types of antihypertensive drugs that do not meet the formulary requirements in the Inpatient Pharmacy of Hospital X. Method: using a descriptive observational design carried out retrospectively. Data were collected from the medical records of 189 patients who received antihypertensive therapy throughout 2025. Data was collected from the medical records of 189 patients who received antihypertensive therapy throughout 2025, totaling 499 antihypertensive prescription items. Purposive sampling was used to gather samples from all prescriptions that met the inclusion criteria. The data was analyzed descriptively, and the prescription appropriateness percentage was calculated using the formula: appropriateness percentage = (number of appropriate antihypertensive prescription items / total number of antihypertensive prescription items) × 100%.Result: that the level of appropriateness of antihypertensive drug prescriptions to the National Formulary (Fornas) and the Hospital Formulary was 86.2% (430 items), while 13.8% (69 items) were not appropriate, mainly in the diuretic group (furosemide and spironolactone), alpha-blockers (tamsulosin), and diltiazem tablets. The Angiotensin Receptor Blocker (ARB) and Calcium Channel Blocker (CCB) groups were the most frequently prescribed. Conclusion: Prescription appropriateness at Hospital X is considered high but has not reached 100%, so regular evaluation by the Pharmacy and Therapeutics Committee is still necessary.
Downloads
References
[1] World Health Organization. (2025). Hypertension. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/hypertension
[2] Kementerian Kesehatan Republik Indonesia. (2023). Survei Kesehatan Indonesia (SKI) dalam Angka. Badan Kebijakan Pembangunan Kesehatan (BKPK) Kemenkes RI.
[3] James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Narva, A. S., & Ortiz, E. (2014). 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520. https://doi.org/10.1001/jama.2013.284427
[4] Sintha, P., Irawan, Y., & Makani, M. (2023). Evaluasi Kesesuaian Peresepan dengan Formularium Nasional di Puskesmas Arut Selatan Pangkalan Bun Periode Oktober–Desember 2022. Jurnal Borneo Cendekia, 7(1), 57–66
[5] Yuliana, I., Pratama, K. J., & Septiarini, A. D. (2023). Kesesuaian Penggunaan Obat Antihipertensi pada Pasien BPJS Rawat Inap dengan Formularium Rumah Sakit di RSUD Dr. Moewardi Surakarta. MEDFARM: Jurnal Farmasi dan Kesehatan, 12(2), 209–219. https://doi.org/10.48191/medfarm.v12i2.
[6] Apriliany, W., Pramukantoro, G. E., & Wijayanti, T. (2023). Analisis Penggunaan Obat Antihipertensi pada Pasien Program Rujuk Balik (PRB) di Apotek Kabupaten “A” Dengan Metode ATC/DDD dan DU 90%. Jurnal Farmasi Komunitas, 10(1), 97–103. https://doi.org/10.20473/jfk.v10i1.38159
[7] James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., Smith, S. C., Svetkey, L. P., Taler, S. J., Townsend, R. R., Wright, J. T., Narva, A. S., & Ortiz, E. (2014). 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA, 311(5), 507–520. https://doi.org/10.1001/jama.2013.284427
[8] Kementerian Kesehatan Republik Indonesia. (2016). Peraturan Menteri Kesehatan Republik Indonesia Nomor 72 Tahun 2016 tentang Standar Pelayanan Kefarmasian di Rumah Sakit. Kemenkes RI.
[9] Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., Wainford, R. D., Williams, B., & Schutte, A. E. (2020). 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75(6), 1334–1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026.
[10] Rashikh, M. A., Alruways, A. F., Alotaibi, H. B., Alotaibi, N. A., Almarshad, F., Alsaab, S. M., & Alotaibi, G. (2023). Blood Pressure Control and Prescription Pattern of Antihypertensive Drugs in Adherence to the 2020 International Society of Hypertension (ISH) Global Hypertension Practice Guidelines in Saudi Arabia: A Retrospective Study. Cureus, 15(2), e34965. https://doi.org/10.7759/cureus.34965.
[11] Kementrian Kesehatan Republik Indonesia. (2019). Pedoman Penerapan Formularium Nasional. Kemenkes RI.”
[12] Abdelkader, N. N., Awaisu, A., Elewa, H., & El Hajj, M. S. (2023). Prescribing patterns of antihypertensive medications: A systematic review of literature between 2010 and 2020. Exploratory Research in Clinical and Social Pharmacy, 11, 100315. https://doi.org/10.1016/j.rcsop.2023.100315
[13] Sorato, M. M., Davari, M., Kebriaeezadeh, A., Sarrafzadegan, N., & Shibru, T. (2022). Antihypertensive prescribing pattern, prescriber adherence to ISH 2020 guidelines, and implication of outpatient drug price on blood pressure control at selected hospitals in Southern Ethiopia. European Journal of Clinical Pharmacology, 78(9), 1487–1502. https://doi.org/10.1007/s00228-022-03352-9
[14] Rabiulyati, M., & Nurwahyuni, A. (2023). Strategi Efisiensi Rumah Sakit di Era JKN: Literature Review. Jurnal Kesehatan Tambusai, 4(2), 2579–2592. https://doi.org/10.31004/jkt.v4i2.15562.
[15] Sikala, S., Distinarista, H., & Rahayu, T. (2025). Faktor–Faktor yang Mempengaruhi Kejadian Hipertensi pada Lansia di RS Bhayangkara Tk. II Jayapura. Jurnal Siti Rufaidah, 3(3), 298-318.
[16] Hamid, Z., Anggraini, N. A., & Wahjuni, C. U. (2026). Pengembangan Indeks Prediksi Risiko Hipertensi Berdasarkan Indeks Massa Tubuh (IMT) dan Rasio Lingkar Pinggang-Pinggul (RLPP) pada Pasien Dewasa di Puskesmas Wonokasian Kabupaten Sidoarjo. Jurnal Ragam Pengabdian, 3(2), 8170-8184.
[17] Anggraini, N., Yanuarto, T., & Dharmayanti, L. (2026). Drug Related Problems Pasien Hipertensi di KLinik" X" Kota Bengkulu Periode 2024. Jurnal Komunitas Farmasi Nasional, 6(01).
[18] Irawan, Y., Makani, M., Billi, J., Ramadhan, F. D., Al-amin, M. I., & Rahmi, N. F. (2024). Evaluasi Penggunaan Obat Antihipertensi pada Pasien Hipertensi Disertai Diabetes Mellitus Rawat Inap di RSUD Sultan Imanuddin Pangkalan Bun Kalimantan Tengah Tahun 2023. Jurnal Borneo Cendekia, 8(1), 122–126. https://doi.org/10.54411/jbc.v8i1.533
[19] Marbun, Romauli Anna Teresia, et al. "Sosialisasi dan Evaluasi Penggunaan Obat Antihipertensi pada Mahasiswa Farmasi Institut Kesehatan Medistra Lubuk Pakam." Jurnal Pengabdian Masyarakat Ilmu Kesehatan 5.1 (2024): 35-39.
[20] Afifah, H., Dewi, I. P., RACHMAWATI, E., HOLIDAH, D., & NORCAHYANTI, I. (2024). Drug interaction study in type 2 diabetes mellitus with hypertension patients at X Hospital, Jember Regency. Jurnal Farmasimed (Jfm), 6(2), 131-141.
[21] Sebayang, L. B., Marbun, R. A. T., & Kartika, D. (2021). Efektivitas Kerasionalan Pemberian Antidiabetik Pengobatan Oral Pasien Diabetes Mellitus pada Usia 30-50 tahun tipe 2 di Rawat Inap Penyakit dalam RSUD Deli Serdang Lubuk Pakam tahun 2020. Jurnal farmasimed (JFM), 3(2), 74-80.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Khairunnisa Fathya Sari, Avianti Eka Dewi Aditya Purwaningsih, Dwi Retna S
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright in each article is the property of the Author.
